Legal & General Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,940
| Closed | -$7.83K | – | 3558 |
|
|
2025
Q1 | $7.83K | Hold |
4,940
| – | – | ﹤0.01% | 3219 |
|
|
2024
Q4 | $15K | Hold |
4,940
| – | – | ﹤0.01% | 3138 |
|
|
2024
Q3 | $18.2K | Sell |
4,940
-48,378
| -91% | -$178K | ﹤0.01% | 3085 |
|
|
2024
Q2 | $218K | Sell |
53,318
-3,485
| -6% | -$14.3K | ﹤0.01% | 2652 |
|
|
2024
Q1 | $895K | Buy |
56,803
+1,226
| +2% | +$19.3K | ﹤0.01% | 2230 |
|
|
2023
Q4 | $842K | Sell |
55,577
-186
| -0.3% | -$2.82K | ﹤0.01% | 2259 |
|
|
2023
Q3 | $1.12M | Buy |
55,763
+854
| +2% | +$17.1K | ﹤0.01% | 2149 |
|
|
2023
Q2 | $1.55M | Buy |
54,909
+15,638
| +40% | +$441K | ﹤0.01% | 2038 |
|
|
2023
Q1 | $675K | Buy |
39,271
+1,158
| +3% | +$19.9K | ﹤0.01% | 2247 |
|
|
2022
Q4 | $768K | Buy |
38,113
+393
| +1% | +$7.92K | ﹤0.01% | 2223 |
|
|
2022
Q3 | $817K | Buy |
37,720
+2,229
| +6% | +$48.3K | ﹤0.01% | 2207 |
|
|
2022
Q2 | $998K | Buy |
35,491
+9,791
| +38% | +$275K | ﹤0.01% | 2158 |
|
|
2022
Q1 | $1.19M | Buy |
25,700
+15,650
| +156% | +$722K | ﹤0.01% | 2187 |
|
|
2021
Q4 | $845K | Buy |
10,050
+1,262
| +14% | +$106K | ﹤0.01% | 2276 |
|
|
2021
Q3 | $585K | Buy |
8,788
+4,242
| +93% | +$282K | ﹤0.01% | 2379 |
|
|
2021
Q2 | $241K | Buy |
4,546
+355
| +8% | +$18.8K | ﹤0.01% | 2489 |
|
|
2021
Q1 | $182K | Buy |
4,191
+98
| +2% | +$4.26K | ﹤0.01% | 2473 |
|
|
2020
Q4 | $212K | Buy |
4,093
+2,728
| +200% | +$141K | ﹤0.01% | 2410 |
|
|
2020
Q3 | $45K | Sell |
1,365
-314
| -19% | -$10.4K | ﹤0.01% | 2730 |
|
|
2020
Q2 | $81K | Buy |
+1,679
| New | +$81K | ﹤0.01% | 2589 |
|